Again, we recently demonstrated that CD11b+ myeloid cells (but not TAM) derived from the tumor of irradiated mice will take up and present locally injected E7 peptide, rendering them susceptible to killing by E7-specific T cells [55]. This evidence concerns the gene ITGAM and neoplasm.